EZH2 inhibition overcomes immunomodulatory drug resistance in multiple myeloma via a cereblon-dependent pathway. - Li Y; Wilson A; Chrisochoidou Y; Martin S; Bird S; Morales S; Leiro M; Kozik Z; Crump NT; Roumeliotis TI; Choudhary J; Pawlyn C (Haematologica, 2026)